The FDA should continue to oversee AI in medical imaging, while Congress, regulators and product developers from other industries address the regulatory concerns of other forms and applications AI.
While Congress, regulators, and product developers in various industries address the variety of governmental concerns in different forms and applications of AI, the FDA should continue to be in charge of overseeing AI in medical imaging. While Congress, regulators, and product developers in various industries address the variety of regulatory concerns in different forms and applications of AI, the FDA should continue to be in charge of overseeing AI in medical imaging.
The FDA should continue to oversee AI in medical imaging, while Congress, regulators and product developers from other industries address the regulatory concerns of other forms and applications AI.
